Action Alert: Support HR 4299 - "Protecting Patient Access to Cancer and Complex Therapies Act" 

 Safeguard Access to Critical Medications!

Urge Your Congressional Members to Cosponsor and Pass HR 4299!

The Association of Women in Rheumatology (AWIR) needs your help! The Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299) is vital legislation that aims to improve medication access for patients requiring complex therapies by removing provider middlemen in drug negotiations, stabilizing physician add-on payments, and ensuring fair reimbursement and savings. Use our letter template to contact your representatives and urge them to support HR 4299!

What's at Stake?

Without this legislation, provider negotiations over drug prices can impact medication availability and affordability. HR 4299 is designed to:

• Remove physicians from the middle of government price negotiations with pharmaceutical manufacturers, enabling more direct and transparent pricing.
• Stabilize physician add-on payments for Part B drugs selected under the Medicare Drug Price Negotiation Program.
• Ensure that provider payments for certain drugs or biologics are restored to 106% of the ASP or WAC, whichever is lower.
• Protect beneficiary cost-sharing, ensuring immediate savings for patients.

Why is HR 4299 Important?

• Ensures Fair Reimbursement: Restores provider payments to support the continued availability of essential medications.
• Supports Patients: Safeguards access to complex therapies by promoting transparency and stability in drug pricing.
• Creates Savings: Facilitates government and beneficiary savings by removing unnecessary middlemen from negotiations.

Take Action Now!

It takes just a moment to make your voice heard! Please insert your information into the template and send the prepared message. We also highly encourage you to personalize the letter to make your support clearer.

Thank you for advocating for patients needing access to complex therapies! Together, we can help ensure that critical medications remain accessible and affordable.